(Q33979445)

30 July 2017

title

Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: implications for breakpoint determinations (English)

1 reference

30 July 2017

main subject

Streptococcus pneumoniae

1 reference

1 reference

D P Nicolau

1

1 reference

30 July 2017

C O Onyeji

2

1 reference

30 July 2017

M Zhong

3

1 reference

30 July 2017

P R Tessier

4

1 reference

30 July 2017

M A Banevicius

5

1 reference

30 July 2017

C H Nightingale

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

44

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

1291-1295

1 reference

Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89857

In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89857

Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89857

Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89857

Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89857

Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89857

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89857

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89857

Pharmacokinetics of cefprozil in infants and children

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89857

Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89857

Comparative trial of cefprozil vs. amoxicillin clavulanate potassium in the treatment of children with acute otitis media with effusion.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89857

Simultaneous high-performance liquid chromatographic analysis of cefprozil diastereomers in a pharmacokinetic study

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10770764

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oral absolute bioavailability and intravenous dose-proportionality of cefprozil in humans

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10770764

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cefprozil treatment of persistent and recurrent acute otitis media

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10770764

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.44.5.1291-1295.2000

1 reference

30 July 2017

1 reference

30 July 2017

1 reference